REKTOROVÁ, Irena, Ivan REKTOR, Martin BAREŠ, V. DOSTÁL, Edvard EHLER, Zuzana FANFRDLOVÁ, Jiří FIEDLER, Hana KLAJBLOVÁ, P. KULIŠŤÁK, Pavel RESSNER, J. SVÁTOVÁ, Karel URBÁNEK and Jana VELÍSKOVÁ. Pramipexole and pergolide in the treatment of depression in Parkinson's disease:a national multicentre prospective randomized study. European Journal of Neurology. Oxford: Blackwell Science, vol. 10, No 10, p. 399-406. ISSN 1351-5101. 2003.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Pramipexole and pergolide in the treatment of depression in Parkinson's disease:a national multicentre prospective randomized study.
Authors REKTOROVÁ, Irena (203 Czech Republic, guarantor), Ivan REKTOR (203 Czech Republic), Martin BAREŠ (203 Czech Republic), V. DOSTÁL (203 Czech Republic), Edvard EHLER (203 Czech Republic), Zuzana FANFRDLOVÁ (203 Czech Republic), Jiří FIEDLER (203 Czech Republic), Hana KLAJBLOVÁ (203 Czech Republic), P. KULIŠŤÁK (203 Czech Republic), Pavel RESSNER (203 Czech Republic), J. SVÁTOVÁ (203 Czech Republic), Karel URBÁNEK (203 Czech Republic) and Jana VELÍSKOVÁ (203 Czech Republic).
Edition European Journal of Neurology, Oxford, Blackwell Science, 2003, 1351-5101.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.000
RIV identification code RIV/00216224:14110/03:00009457
Organization unit Faculty of Medicine
UT WoS 000183687100009
Keywords in English depression;dopamine receptor agonists;Parkinson's disease
Tags Depression, dopamine receptor agonists, Parkinson's disease
Changed by Changed by: prof. MUDr. Irena Rektorová, Ph.D., učo 26922. Changed: 26/6/2009 15:58.
Abstract
An 8-month multicentre prospective randomized study aimed at comparing the effects of dopamine receptor agonists pramipexole as add-on to L-dopa therapyon depression in 41 non-demented patients suffering from both mild or moderate depression and advanced Parkinson's disease.
PrintDisplayed: 20/4/2024 08:03